Medios AG
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. The company operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic preparations, antibody therapies, a… Read more
Medios AG (MEDOF) - Total Liabilities
Latest total liabilities as of September 2025: $421.22 Million USD
Based on the latest financial reports, Medios AG (MEDOF) has total liabilities worth $421.22 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Medios AG - Total Liabilities Trend (2009–2024)
This chart illustrates how Medios AG's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Medios AG Competitors by Total Liabilities
The table below lists competitors of Medios AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Varex Imaging Corp
NASDAQ:VREX
|
USA | $607.20 Million |
|
Farmland Partners Inc
NYSE:FPI
|
USA | $180.15 Million |
|
DroneShield Limited
PINK:DRSHF
|
USA | $38.99 Million |
|
The ODP Corporation
MX:ODP
|
Mexico | MX$2.46 Billion |
|
Retailors Ltd
PINK:RTALF
|
USA | $2.25 Billion |
|
Dark Horse Beijing Technology Co Ltd
SHE:300688
|
China | CN¥157.33 Million |
|
First Tractor Company Limited
PINK:FIRRF
|
USA | $7.83 Billion |
Liability Composition Analysis (2009–2024)
This chart breaks down Medios AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.74 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.81 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medios AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medios AG (2009–2024)
The table below shows the annual total liabilities of Medios AG from 2009 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $424.17 Million | +236.78% |
| 2023-12-31 | $125.95 Million | -1.54% |
| 2022-12-31 | $127.91 Million | -1.59% |
| 2021-12-31 | $129.98 Million | +149.42% |
| 2020-12-31 | $52.11 Million | +49.14% |
| 2019-12-31 | $34.94 Million | +25.15% |
| 2018-12-31 | $27.92 Million | +74.17% |
| 2017-12-31 | $16.03 Million | +16.48% |
| 2016-12-31 | $13.76 Million | +7321.68% |
| 2015-12-31 | $185.43K | +106.53% |
| 2014-12-31 | $89.78K | -60.37% |
| 2013-12-31 | $226.54K | -15.52% |
| 2012-12-31 | $268.14K | -4.48% |
| 2011-12-31 | $280.72K | -45.84% |
| 2010-12-31 | $518.32K | -117.75% |
| 2009-12-31 | $-2.92 Million | -- |